Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMelrose Regulatory News (MRO)

Share Price Information for Melrose (MRO)

Share Price is delayed by 15 minutes
Get Live Data
453.70    -5.90 (-1.28%)
Bid:
454.70
Ask:
454.90
Spread: 0.20 (0.044%)
Market Cap: £5.65b
MRO Live PriceLast checked at - London Stock Exchange

Intraday Melrose Share Chart

Disposal

6 Jun 2022 07:00

RNS Number : 6934N
Melrose Industries PLC
06 June 2022
 

3 June 2022

MELROSE INDUSTRIES PLC

 

SALE OF ERGOTRON

 

Sale of Ergotron

Melrose Industries PLC ("Melrose", the "Company" or the "Group") has entered into an agreement to sell its Ergotron business ("Ergotron"), to funds managed by The Sterling Group ("Sterling") for total consideration of approximately $650 million (c.£520 million), payable in cash on completion (the "Disposal"). Ergotron is a leading designer, manufacturer and distributor of ergonomic products for use in a variety of working, learning and healthcare environments, with gross assets (mostly goodwill) as at 31 December 2021 of £617 million and 2021 adjusted operating profit of £58 million (2021 EBITDA £62 million). 

Completion of the Disposal is expected to occur in the third quarter of 2022 ("Completion") and is conditional upon customary US antitrust approvals. On or before Completion, Melrose will announce how it intends to use the net proceeds from the Disposal. 

 

Successful execution of Melrose's strategy for Nortek

Having sold the Nortek Air Management and Nortek Control businesses last year, Ergotron is the last of the businesses remaining from the Nortek Inc acquisition in 2016. On Completion, Melrose will have more than doubled shareholders' initial investment, whilst transforming the Nortek businesses themselves.

Refocusing them away from unprofitable work, Melrose made the significant investment necessary to implement operational best practices, increase R&D, develop new products and build stronger customer relationships. These actions resulted in an almost doubling of adjusted operating margins and ensured each business remained highly cash generative, with over $1 billion generated during Melrose ownership.

This strong support and appropriate investment under Melrose ownership unlocked the potential of all the Nortek businesses and set them on the path for further success under new owners for the next stage of their development. 

 

Simon Peckham, Chief Executive of Melrose, today said:

"The sale of Ergotron is the final step in our Nortek ownership cycle, capping what has been a very successful acquisition for Melrose shareholders. We will have more than doubled shareholders' equity investment in Nortek and have transformed the businesses themselves. Our attention now remains firmly on achieving the same result for the current Group." 

 

Enquiries:

Investor Relations:

+44 (0) 7974 974690

ir@melroseplc.net

 

Montfort Communications - Financial PR:

+44 (0) 20 3514 0897

Nick Miles miles@montfort.london

+44 (0) 7739 701634

Charlotte McMullen mcmullen@montfort.london

+44 (0) 7921 881 800

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DISBCGDLXXGDGDU
Date   Source Headline
23rd Aug 20185:07 pmRNSHolding(s) in Company
23rd Aug 20185:06 pmRNSHolding(s) in Company
22nd Aug 20187:00 amRNSNotice of Results
21st Aug 201811:59 amRNSHolding(s) in Company
20th Aug 20186:13 pmRNSHolding(s) in Company
16th Aug 20185:41 pmRNSHolding(s) in Company
10th Aug 20184:09 pmRNSHolding(s) in Company
8th Aug 20184:02 pmRNSVoting Rights and Capital
8th Aug 20181:39 pmRNSHolding(s) in Company
31st Jul 201811:49 amRNSHolding(s) in Company
30th Jul 20189:18 amRNSHolding(s) in Company
5th Jul 20182:25 pmRNSHolding(s) in Company
4th Jul 20184:59 pmRNSHolding(s) in Company
26th Jun 20181:05 pmRNSVoting Rights and Capital
26th Jun 201810:44 amRNSDirector/PDMR Shareholding
25th Jun 20187:00 amRNSCFIUS Clearance
8th Jun 201812:00 pmRNSPDMR Notification
31st May 20182:43 pmRNSVoting Rights and Capital
30th May 20186:04 pmRNSHolding(s) in Company
30th May 201811:36 amRNSHolding(s) in Company
25th May 20184:20 pmRNSDirector/PDMR Shareholding
24th May 20183:08 pmRNSVoting Rights and Capital
22nd May 20184:39 pmRNSHolding(s) in Company
22nd May 20184:34 pmRNSHolding(s) in Company
22nd May 20184:33 pmRNSHolding(s) in Company
22nd May 20184:32 pmRNSHolding(s) in Company
21st May 201810:56 amRNSHolding(s) in Company
21st May 20188:00 amRNSDelisting of GKN & Continuation Of Offer
18th May 20183:54 pmRNSHolding(s) in Company
17th May 20182:59 pmRNSVoting rights and capital
10th May 201812:01 pmRNSResult of AGM
10th May 20187:00 amRNSAGM Trading Update
9th May 20186:14 pmRNSHolding(s) in Company
8th May 20189:18 amRNSHolding(s) in Company
3rd May 20186:11 pmRNSHolding(s) in Company
2nd May 20187:00 amRNSHolding(s) in Company
1st May 20183:47 pmRNSVoting Rights and Capital
1st May 20182:20 pmRNSHolding(s) in Company
27th Apr 20187:00 amRNSCompulsory Acquisition of remaining GKN Shares
26th Apr 20186:03 pmRNSHolding(s) in Company
26th Apr 201810:17 amRNSHolding(s) in Company
25th Apr 20184:09 pmRNSHolding(s) in Company
25th Apr 201810:39 amRNSHolding(s) in Company
24th Apr 20183:19 pmRNSStatement re deeds of undertaking
24th Apr 20187:03 amRNSTRADING UPDATE FOR GKN PRIOR TO MELROSE OWNERSHIP
24th Apr 20187:00 amRNSHolding(s) in Company
24th Apr 20187:00 amRNSHolding(s) in Company
23rd Apr 20185:52 pmRNSHolding(s) in Company
23rd Apr 20185:50 pmRNSHolding(s) in Company
23rd Apr 20185:39 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.